NCT03348306View on ClinicalTrials.gov

Multi-organ Screening for Asymptomatic Ischaemia in Antiphospholipid Syndrome

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 20, 2018

Primary Completion Date

January 14, 2022

Study Completion Date

January 14, 2022

Conditions
Antiphospholipid Syndrome
Interventions
DEVICE

MRI

Brain and cardiac MRI in one time with gadolinium injection.

BIOLOGICAL

Blood sample collection

A blood sampling is also collected for hematocrit measure.

Trial Locations (1)

54000

CHRU Nancy Brabois, Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT03348306 - Multi-organ Screening for Asymptomatic Ischaemia in Antiphospholipid Syndrome | Biotech Hunter | Biotech Hunter